# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Grants for Injury Control Research Centers (Panel 3), Funding Opportunity Announcement (FOA) CE12-001, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned SEP:
*Time and Date:* 8:30 a.m.-5 p.m., February 21-22, 2012 (Closed).
*Place:* Crowne Plaza Atlanta Perimeter Hotel at Ravinia, 4355 Ashford Dunwoody Rd, Atlanta, Georgia 30346 Telephone: (770) 395-7700.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters To Be Discussed:* The meeting will include the initial review, discussion, and evaluation of applications received in response to “Grants for Injury Control Research Centers, Panel 3, FOA CE12-001.”
Contact Person for More Information: Donald Blackman, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone (770) 488-0641.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: January 11, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.